PCOS and Insulin Resistance: The Ovarian-Metabolic Axis and Hyperandrogenism
Understanding Polycystic Ovary Syndrome as an endocrine and metabolic condition driven by hyperinsulinemia stimulating ovarian theca cell androgen production.
Clinical definitions, symptoms, pathophysiology, and therapeutic pathways for metabolic disorders.
Understanding Polycystic Ovary Syndrome as an endocrine and metabolic condition driven by hyperinsulinemia stimulating ovarian theca cell androgen production.
A comprehensive clinical overview of Metabolic Syndrome (Syndrome X), covering ATP III criteria, endothelial damage, atherogenic dyslipidemia, and first-line clinical interventions.
A deep dive into hepatic fat accumulation, non-invasive FIB-4 scores, progression to MASH (NASH), and clinical nutritional reversibility.
Designed by board-certified physicians to break through fat loss plateaus, reset hypothalamic leptin sensitivity, and suppress baseline insulin spikes in 7 days.